Research use only. Not for human or veterinary use.
Lab reports
Analysis reportAll specifications met

Retatrutide 5mg

Peptide Stock ref. PSV-2609-RT05-02

Lot
CP0126072125L
Manufactured
21 July 2026
Tested by
Accumark Labs
Analysed
24 September 2026
Purity99.74%HPLC
Content per vial5.112 mg102.2% of 5 mg label claim
IdentityConfirmedHPLC

Test results

TestSpecificationResultOutcome
IdentityRetatrutideConformsPass
Purity (HPLC)> 98.0%99.737%Pass
Quantity per vialMeasured5.112 mg (102.2% of claim)Reported

About this report

Analysis reportAll specifications met

Retatrutide 5mg

Peptide Stock ref. PSV-2609-RT05-01

Lot
CP0126072125L
Manufactured
21 July 2026
Tested by
Accumark Labs
Analysed
11 September 2026
Purity99.67%HPLC
Content per vial4.85 mg97.0% of 5 mg label claim
IdentityConfirmedHPLC

Test results

TestSpecificationResultOutcome
IdentityRetatrutideConformsPass
Purity (HPLC)> 98.0%99.67%Pass
Quantity per vialMeasured4.85 mg (97.0% of claim)Reported

About this report

← All lab reports